You are here

Chimerix Presents Results from Post-hoc Analysis of Phase 3 Study

Decreased HHV-6 Reactivation Observed Among Oral Brincidofovir Allogeneic Hematopoietic Cell Transplantation Recipients
Friday, February 22, 2019 - 08:00